Dilated Cardiomyopathy 1nn C4014656
A genetic heart condition where the main pumping chamber enlarges and weakens, reducing blood flow. It can run in families. Treatment includes medications, pacemakers, or heart transplant.
Key facts at a glance
- ICD-10
- B33.24
- ICD-11
- 1A00.0
- Body system
- cardiovascular
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Chest discomfort or palpitations
(cardiovascular)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Dyspnea (shortness of breath)
(cardiovascular)Fatigue
(cardiovascular)Peripheral edema
(cardiovascular)Palpitations
(cardiovascular)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Disease management and monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Guideline-Directed Medical Therapy Combination
Multi-drug regimens combining ACE inhibitors, beta-blockers, and aldosterone antagonists form the cornerstone of severe DCM management. This comprehensive pharmacological approach addresses multiple neurohormonal pathways to optimize outcomes.
Alcohol Cessation and Cardiac Protection
Complete abstinence from alcohol is mandatory as ethanol is directly cardiotoxic. Additionally, elimination of tobacco use and avoidance of cardiotoxic substances protects remaining myocardial function.
Additional treatment options
Cardiac Resynchronization Therapy
Biventricular pacing coordinates ventricular contraction in DCM patients with bundle branch block, improving cardiac output and exercise tolerance. CRT reduces mitral regurgitation and promotes favorable cardiac remodeling.
procedureHeart Transplant Listing
For qualifying patients with refractory severe DCM, heart transplantation offers definitive treatment with excellent long-term survival. Multidisciplinary teams manage listing, bridging strategies, and post-transplant immunosuppression.
surgicalAdvanced Hemodynamic Monitoring
Implantable pulmonary artery pressure sensors enable remote monitoring of filling pressures, allowing proactive medication adjustments before symptoms develop. This technology reduces heart failure hospitalizations.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Dilated Cardiomyopathy 1nn C4014656?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Dilated Cardiomyopathy 1nn C4014656. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy